Evaluation of response to pneumococcal vaccination in patients with rheumatoid arthritis receiving upadacitinib: results from a phase 2 open-label extension study

Authors
Category Primary study
JournalAnnals of the Rheumatic Diseases
Year 2021
This article has no abstract
Epistemonikos ID: da3fb3cb3afdd38f3870f71675da96fe50560b6b
First added on: Feb 13, 2025